Is the death knell for cytotoxic manufacturing in hospitals ringing? [5]

Journal of Pharmacy Practice and Research

Volumn 36, Issue 1, 2006, Pages 78-79

  Siderov, Jim ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; IRRITANT AGENT; VOLATILE AGENT;

ALERTNESS; BIOSAFETY; DRUG CONTAMINATION; DRUG DOSAGE FORM; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG STORAGE; ENVIRONMENTAL PROTECTION; FILTER; HEALTH CARE PERSONNEL; HOSPITAL PHARMACY; LAMINAR FLOW; LETTER; MATERIALS HANDLING; PACKAGING MATERIAL; PHARMACIST; PRACTICE GUIDELINE;

EID: 33646509449     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Gilbar P. External contamination of cytotoxic drug vials [editorial]. J Pharm Pract Res 2005; 35: 264-5.
2. Sessink PJ, Anzion RB, Van den Broek PHH, Bos RP. Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharm Weekbl Sci 1992; 14: 16-22.
3. Connor TH, Anderson RW, Sessink PJ, Broadfield L, Power LA. Surface contamination with antineoplastic agents in six cancer treatment centres in Canada and the United States. Am J Health Syst Pharm 1999; 56: 1427-32.
4. Schulz H, Bigelow S, Dobish R, Chambers CR. Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy Perspective. J One Pharm Pract 2005; 11: 101-9.
5. Graham BM. Cytotoxic drug safety cabinets [letter]. Aust J Hosp Pharm 1999; 29: 291.